Contact
Start a qualified business conversation.
Review the appropriate business-enquiry route and the information that should never be submitted through an unverified channel.
Corporate enquiries
Tell us what you are working on.
NovaPharm reviews B2B enquiries against strategic fit, regulatory status, evidence quality and next-step requirements. The contact route is not a patient or adverse-event reporting channel.
Product and dossier opportunitiesOncology & specialist medicinesUK distribution partnershipsClinical development & CRO supportPharmacy and wholesaler accountsCMO/CDMO collaborationRegulatory and quality servicesSupplier, media and career enquiries